Nucleus Chem Oil Private Limited
Produces and sells a wide range of chemicals and pharmaceutical products.
2001 | Mumbai, Maharashtra (India) | Under Liquidation
Nucleus Chem Oil Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 2.20 M
- Company Age 23 Year, 10 Months
- Last Filing with ROC 31 Mar 2013
- Open Charges ₹ 3.65 Cr
- Satisfied Charges ₹ 6.50 M
About Nucleus Chem Oil
Nucleus Chem Oil Private Limited (NCOPL) is Under Liquidation company established on 04 Apr 2001 with its office registered at Mumbai, Maharashtra, India and has been running since 23 Year, 10 Months with a paid up capital of 2.20 M. According to MCA records, 3 Directors are linked to this company as of 14 May 2024.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24117MH2001PTC131504
- Company No.
131504
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Apr 2001
- Date of AGM
27 Sep 2013
- Date of Balance Sheet
31 Mar 2013
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Chemicals and Materials
Who are the key members and board of directors at Nucleus Chem Oil?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dayal Mansukhani  | Director | 04-Apr-2001 | Current |
| Kavita Mansukhani | Director | 17-Mar-2012 | Current |
| Alkesh Mansukhani | Director | 21-Jun-2012 | Current |
Financial Performance of Nucleus Chem Oil.
Enhance accessibility to Nucleus Chem Oil's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Nucleus Chem Oil?
Unlock access to Nucleus Chem Oil's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹36.50 M
Satisfied Charges
₹6.50 M
Charges Breakdown by Lending Institutions
- Dhanlaxmi Bank Limited : 2.00 Cr
- Bank Of India : 1.65 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Mar 2013 | Bank Of India | ₹1.65 Cr | Open |
| 12 Oct 2011 | Dhanlaxmi Bank Limited | ₹1.00 Cr | Open |
| 24 Sep 2011 | Dhanlaxmi Bank Limited | ₹1.00 Cr | Open |
| 13 Jul 2001 | Idbi Bank Limited | ₹6.50 M | Satisfied |
How Many Employees Work at Nucleus Chem Oil?
Unlock and access historical data on people associated with Nucleus Chem Oil, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nucleus Chem Oil, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nucleus Chem Oil's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
